2023-05-15T11:08:31-05:00 2022-12-31 042513210 GERALD T REILLY & COMPANY 424 ADAMS STREET MILTON MA 02186 990 2022-01-01 814905853 CU KIDS AT HEART INC CUKI 7819339950 35 CORPORATE DRIVE 300 BURLINGTON MA 01803 DAVID HOANG TREASURER 7819339950 2023-05-12 1 DAVID HOANG 999009999 1 KEVIN BONNETT CPA P01384136 6176968900 2023-05-10 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z JANE MELCHIONDA 35 CORPORATE DRIVE BURLINGTON MA 01803 460337 0 X WWW.CREDITUNIONSKIDSATHEART.ORG X 2016 MA TO HELP CHILDREN LEAD HEALTHY AND HAPPY LIVES THROUGH THE FUNDING OF MEDICAL RESEARCH ACTIVITIES. 5 5 0 10 0 0 436674 448645 0 0 116 1377 6574 5692 443364 455714 615918 452403 0 0 0 0 0 0 0 10397 6252 626315 458655 -182951 -2941 249995 247354 3700 4000 246295 243354 TO HELP CHILDREN LEAD HEALTHY AND HAPPY LIVES THROUGH THE FUNDING OF RESEARCH ACTIVITIES AIMED AT THE PREVENTION, TREATMENT AND/OR CURE OF PEDIATRIC NEUROLOGICAL DISEASES. 0 0 452403 452403 448645 THROUGH A VARIETY OF FUNDRAISING EVENTS AND ACTIVITIES, THE ORGANIZATION COLLECTS DONATIONS FROM THE EMPLOYEES, MEMBERS, AND PHILANTHROPIC CONTRIBUTIONS OF CREDIT UNIONS THROUGHOUT THE UNITED STATES; SUPPORTING CORPORATIONS; AND THE GENERAL PUBLIC. DONATIONS RAISED BY THE ORGANIZATION ARE DISTRIBUTED TO VARIOUS NON-PROFIT ENTITIES TO FUND MEDICAL RESEARCH IN LINE WITH THE ORGANIZATIONAL MISSION. THE ORGANIZATION ALSO WORKS TO RAISE AWARENESS OF RARE PEDIATRIC DISEASES AND RELATED MEDICAL RESEARCH. 452403 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MA X DAVID HOANG 7819339950 35 CORPORATE DRIVE BURLINGTON MA 01803 X JANE MELCHIONDA CHAIRMAN 1.00 X X 0 0 0 DAVID HOANG TREASURER 2.00 X X 0 0 0 ROBERT BARTOL SECRETARY/CLERK 1.00 X X 0 0 0 CYNTHIA NELSON DIRECTOR 1.00 X 0 0 0 ASIM MIAN DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 0 448645 448645 1377 1377 10000 3365 6635 6635 315 1258 -943 -943 455714 0 0 7069 452403 452403 4000 4000 756 756 MERCHANT SERVICE FEES 1496 1496 458655 452403 6252 0 245920 243623 4069 3514 980 980 0 0 6 217 249995 247354 3700 4000 3700 4000 X 186445 223704 59850 19650 246295 243354 249995 247354 -2941 0 X X 1 X 0 1 0 X 461090 448674 420875 443493 448645 2222777 461090 448674 420875 443493 448645 2222777 2222777 29 287 109 116 1377 1918 2224695 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 50000 25000 75000 50000 50000 25000 25000 50000 25000 25000 980 980 0 0 PART V, LINE 4: THE INVESTMENT EARNINGS FROM THE ENDOWMENT FUND WILL BE USED TO PAY FOR ANNUAL OPERATIONAL EXPENSES OF THE ORGANIZATION. DURING 2021 THE DONOR OF THESE ENDOWMENT FUNDS RELEASED THE RESTRICTIONS FOR THE FUNDS TO BE USED TO SUPPORT THE ORGANIZATIONS EXEMPT PURPOSE WHICH HAS BEEN SHOWN AS AN EXPENDITURE IN SCHEDULE D PART V. 1 CHILDRENS HOSPITAL CORPORATION 300 LONGWOOD AVE BOSTON MA 02115 042774441 501C3 352403 0 FUND RESEARCH ACTIVITIES AIMED AT THE PREVENTION, TREATMENT, AND/OR CURE OF PEDIATRIC NEUROLOGICAL DISEASES, INCLUDING MOYAMOYA DISEASE, CEREBRAL PALSY, PEDIATRIC EPILEPSY AND OTHER SEIZURE DISORDERS, AND PEDIATRIC BRAIN CANCER. BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BOSTON MA 02215 042103881 501C3 100000 0 PEDIATRIC BRAIN CANCER RESEARCH TO SUPPORT THE GROUNDBREAKING WORK OF THE PANIGRAHY LAB AT BETH ISRAEL DEACONESS MEDICAL CENTER THROUGH THE CJ BUCKLEY MEMORIAL FUND. 2 FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FORM 990 AND FORM PC IS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS MONITORED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S CORPORATE RECORDS ARE AVAILABLE AT ITS OFFICES DURING REGULAR BUSINESS HOURS. FORM 990, PART XII, LINE 2C: THERE HAS BEEN NO CHANGE IN THE FINANCIAL STATEMENT REVIEW OVERSIGHT OR ACCOUNTANT SELECTION PROCESS FROM THE PRIOR YEARS - THIS IS COMPLETED BY THE BOARD OF DIRECTORS, ALL DIRECTORS WILL OBTAIN, REVIEW AND APPROVE THE FINANCIAL STATEMENTS PRIOR TO ISSUANCE.